◢ SPACE MEDICINE FOUNDATION
⌕ Search
Space weather
Geomagnetic storm level: Loading…
Solar radiation level: Loading…
Loading…
ROUGH DRAFT SITE · Educational use only — not medical advice and not operational guidance. Disclaimer

Home › Learn › Case files › Motion sickness in orbit

DRAFT · NOT REVIEWED — AI-assisted draft for educational use only; not medical advice and not operational guidance. Reviewer: Pending review. Items marked “pending verification” could not be confirmed against a primary source. Disclaimer

Fictional composite case

This case is invented for teaching. It combines typical features from the cited sources and describes no real astronaut, spaceflight participant or patient. No real patient data were used.

LRN-26 · Teaching case (fictional) · Learn

Case File: Space Motion Sickness on a Short Orbital Flight

Gravity FieldsVestibular & SensorimotorGI & NutritionNeurological & CognitiveIn-flightEntry, Descent & LandingPostflight RecoveryLEO short-durationSuborbitalClinicianOperator / SFPPublic

draft AI-assisted Last reviewed: Pending review · Reviewer: Pending review

Bottom line
  • About 70–90% of first-time flyers get space motion sickness, usually in the first 2–3 days [1]. ◆◆◆◆ High · F
  • Promethazine is NASA's treatment of choice; 14 of 15 Shuttle crew treated by injection had relief within 1–2 hours [1][3]. ◆◆◆◇ Moderate · F
  • Symptoms can return after landing with imbalance; plan for falls precautions and no driving [1][5]. ◆◆◆◇ Moderate · F E

Proposed certainty (◆ High → ◇ Very low) and evidence-type tags: F flight · A analog · M model/animal · C computational · E expert/operational/standards. AI-proposed, pending reviewer confirmation. How to read the grades.

Presentation

A 29-year-old first-time flyer is on a 4-day orbital flight. A few hours after reaching orbit she feels nauseated, has a headache and a stuffy, puffy face, and loses her appetite. Turning or nodding her head makes it worse. By the end of day 1 she has vomited twice. She was car-sick as a child but has never flown in space.

Questions

  1. What is happening, and how common is it?
  2. How severe is it by NASA’s grading?
  3. How is it treated?
  4. What should she expect after landing?

Think through your answers before opening the reveals below.

Reveal

Question 1: answer and discussion

What is happening, and how common is it?

Space motion sickness (SMS), also called space adaptation sickness. Most first-time flyers get it, about 70–90% in NASA’s summary, usually in the first 2–3 days, and it typically resolves within about 72 hours [1]. The leading explanation is sensory conflict: without gravity, the inner ear’s otolith organs stop signaling head tilt, which clashes with what the eyes see [2]. Facial puffiness and nasal stuffiness come from the headward fluid shift.

Childhood car sickness does not reliably predict space motion sickness; a previous episode in space does [1].

Question 2: answer and discussion

How severe is it by NASA’s grading?

Moderate (grade 2). NASA’s brief grades mild as a few symptoms with up to one vomiting episode, resolving in 36–48 hours; moderate as persistent malaise with no more than two vomiting episodes, resolving in 72 hours; and severe as more than two vomiting episodes, possibly lasting beyond 72 hours [1].

Question 3: answer and discussion

How is it treated?

  • Behavioral measures: limit head movements (pitch, or nodding, movements are the most provocative), keep a consistent sense of “up”, fix the gaze on a task, avoid strong smells and heat, and drink fluids [1].
  • Promethazine is NASA’s treatment of choice, given by injection or suppository when vomiting [1]. In Space Shuttle crews, 14 of 15 treated by injection had relief within 1–2 hours [3]. Sedation has not commonly been seen in the first days of flight [1].
  • Taking medicine before launch has not shown a clear benefit in NASA data [1].
  • The operator’s flight surgeon sets the medicine plan for each participant.
Question 4: answer and discussion

What should she expect after landing?

Similar symptoms can return after landing, along with dizziness and unsteadiness, as the brain readjusts to gravity [1]. Fluid shifts also cause lightheadedness on standing (orthostatic intolerance) [4]. NASA crew are usually advised not to drive during the first week [5].

For short trips the outlook is good. On the 3-day Inspiration4 flight, almost all measured changes in the civilian crew returned to baseline after landing [6].

Red flags: symptoms beyond 72 hours, getting worse rather than better, focal neurological signs, severe headache, fever, or signs of dehydration. Trouble passing urine is also common early in flight, from fluid shifts and anticholinergic drugs [1].

Teaching points

  • Space motion sickness affects most first-time flyers and usually resolves within 3 days [1].
  • Previous space motion sickness predicts it; car sickness does not reliably do so [1].
  • Promethazine is NASA’s treatment of choice; preflight prophylaxis has not shown clear benefit [1][3].
  • NASA schedules spacewalks after 72 hours of flight, partly to allow symptoms to resolve [1].
  • Expect readaptation symptoms after landing; no driving until balance is back [5].

Read more

Evidence profile
Overall certainty
◆◆◆◇ Moderate (proposed)
Evidence types
F · Flight dataE · Expert / operational / standards
Literature through
2026-10-14
Case data
Fictional composite; no real patient data
Credit
Educational only; no CME or other credit
Requirements referenced 2
RequirementTitlePlain-language meaning
[V1 4005]–[V1 4010]Sensorimotor StandardsSensorimotor function maintained for critical tasks, with countermeasures and readaptation.
[V1 6006]EVA Medical ClearanceEvery crewmember medically cleared by ground medical support before each EVA.

IDs as published in NASA-STD-3001 Vol. 1 Rev C (2023-09-15) and NASA-STD-3001 Vol. 2 Rev F (2026-07-14). NASA-STD-3001 binds NASA programs; it is not a regulation for commercial flights. Paraphrased. Standards quick reference.

References 6
  1. NASA OCHMO. Space Adaptation Sickness (SAS). Medical Technical Brief OCHMO-MTB-004 (2025). www.nasa.gov/wp-content/uploads/2025/09/ochmo-mtb-004-space-… NASA E
  2. Heer M, Paloski WH. Space motion sickness: incidence, etiology, and countermeasures. Auton Neurosci. 2006;129(1–2):77–79. doi:10.1016/j.autneu.2006.07.014 PMID:16935570 Peer-reviewed E
  3. Davis JR, Jennings RT, Beck BG. Comparison of treatment strategies for space motion sickness. Acta Astronaut. 1993;29(8):587–591. doi:10.1016/0094-5765(93)90074-7 PMID:11541638 Peer-reviewed F
  4. NASA OCHMO. Orthostatic Intolerance. Technical Brief OCHMO-TB-019. www.nasa.gov/wp-content/uploads/2023/12/ochmo-tb-019-orthost… NASA E
  5. NASA OCHMO. Crew Medical Support for Entry, Descent, and Landing. Technical Brief OCHMO-TB-051 (2026). www.nasa.gov/wp-content/uploads/2026/05/ochmo-tb-051-crew-me… NASA E
  6. Jones CW, Overbey EG, Lacombe J, et al. Molecular and physiological changes in the SpaceX Inspiration4 civilian crew. Nature. 2024;632:1155–1164. doi:10.1038/s41586-024-07648-x PMID:38862026 Peer-reviewed F

Machine-checked on 2026-10-14: each URL was fetched, each DOI's title/journal/year matched via Crossref, PubMed IDs matched to DOIs, and claims were checked against the source text (abstract, NASA document or official web page). Human verification against full text is still required before review. NASA documents are U.S. Government works (public domain) and are summarized with attribution; journal articles are summarized, not reproduced.

Article info
Authors
Pending (AI-assisted draft)
Reviewer
Pending review
Last reviewed
Pending review
Literature through
2026-10-14
AI-assisted
Yes (disclosed)
COI
Pending
License
CC BY-SA 4.0
Use
Educational only · no CME credit · Disclaimer
Cite this version
Pending first edition

Educational use only · not medical advice · Disclaimer · CC BY-SA 4.0